Correction: Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research
**Correction: Journal of Cancer Research and Clinical Oncology (2022) 148:3385–3398 ** 10.1007/s00432-022-04110-1
In the original version of the article, the Fig. 6I was incorrect. In the Co-immunoprecipitation experiment, the WB blots of the DDR2 in BT20 cells were mistakenly used for twice. Therefore, the WB blots for DDR2 in BT20 cells were unfortunately used for WB blots of IFITM1 in MDA-MB-231 cells in Fig. 6I. The correct figure is provided below.
The original article is updated with the correct Fig. 6I.